Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Myositis × Rituximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 185 Lymphoma, Large B-Cell, Diffuse 178 Lymphoma, Non-Hodgkin 122 Leukemia, Lymphocytic, Chronic, B-Cell 120 Lymphoma, Follicular 113 Lymphoma, Mantle-Cell 100 Lymphoma, B-Cell, Marginal Zone 65 Leukemia 65 Burkitt Lymphoma 55 Waldenstrom Macroglobulinemia 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Recurrence 35 Lymphoma, B-Cell 35 Lymphoma, Large-Cell, Immunoblastic 31 Hodgkin Disease 22 Neoplasms 15 Dendritic Cell Sarcoma, Interdigitating 15 Leukemia, Myeloid, Acute 13 Myelodysplastic Syndromes 12 Lymphoma, Large-Cell, Anaplastic 12 Leukemia, Hairy Cell 12 Multiple Myeloma 10 Leukemia, Myeloid, Accelerated Phase 8 Leukemia, Prolymphocytic 7 Leukemia, Myelomonocytic, Chronic 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Intraocular Lymphoma 7 Hematologic Neoplasms 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Neoplasms, Plasma Cell 6

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00774462 2012-12-11

FORCE

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed

Myasthenia Gravis, Myositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡